List of drugs granted breakthrough therapy designation
This is a list of drugs which granted breakthrough therapy designation by years:
2013
2014
- Ivacaftor
- Ofatumumab
- Ceritinib
- Idelalisib
- Ibrutinib (2nd approval)
- Eltrombopag
- Pembrolizumab
- Ledipasvir/Sofosbuvir
- Nintedanib
- Pirfenidone
- Blinatumomab
- Viekira Pak (ombitasvir, paritaprevir and ritonavir)
- Nivolumab
- Ivacaftor (2nd approval)
- Pimavanserin
- Bexsero
2015
- Ibrutinib (3rd approval)
- Palbociclib
- Ranibizumab
- ivacaftor (3rd approval)
- Aflibercept
- Sirolimus
- Sirolimus (2nd approval)
- Orkambi (Lumacaftor and ivacaftor)
- Technivie (Ombitasvir, paritaprevir and ritonavir)
- uridine triacetate
- Pembrolizumab
- Nivolumab (2nd approval)
- Idarucizumab
- Asfotase alfa (Strensiq)
- Osimertinib
- Daratumumab
- Nivolumab (3rd approval)
- Elotuzumab
- Sebelipase alfa
- Alectinib
- Pembrolizumab (2nd approval)
- Trumenba
- deutetrabenazine
2016
References
This article is issued from Wikipedia - version of the 8/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.